Can Bill Gruber Take Solace Where He Took Interlace?

Medtech Talk
02/07/2015 34 min
Can Bill Gruber Take Solace Where He Took Interlace?

Listen "Can Bill Gruber Take Solace Where He Took Interlace?"

Descargar episodio

Episode Synopsis

Solace Therapeutics CEO Bill Gruber hopes to repeat the successful exit he helped execute when Hologic paid close to $300 million for his previous company Interlace.

More episodes of the podcast Medtech Talk

From Boston Scientific to Entrepreneur: Chas McKhann’s Medtech Journey 26/08/2025
Innovating for Niche Populations with Eric Chehab and James Wall 29/07/2025
Episode: 197 - Fireside Chat: How Michael Mahoney Built a Culture of Disciplined Innovation at Boston Scientific 15/07/2025
Episode: 196 - Eric Wichems on Building a Company You Want to Work For 21/05/2025
Episode: 195 - John Woock on Crossing the Chasm from Clinical to Commercial 29/04/2025
Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation 27/03/2025
Episode:193 - Dr. Billy Cohn on Limitless Innovation and Finding Resources Everywhere 18/02/2025
Episode: 192 - Michael Jaff's Multi-Perspective Insights Into Healthcare 02/12/2024
Episode: 191 - Per Langoe on Bringing New Hope to Brain Cancer Patients 15/10/2024
Episode: 190 - The Evolution of Suki and Bringing Joy Back to Patient Care 17/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA